Concepedia

Publication | Closed Access

Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model

DOI

28

Citations

32

References

2010

Year

Daisuke Sano, David Fooshee, Mei Zhao, Genevieve A. Andrews, Mitchell J. Frederick, Chad E. Galer, Zvonimir L. Milas, Phuong K. Morrow, Jeffrey N. Myers
Head & Neck

Abstract

Vandetanib has the potential to be a novel molecular targeted therapy for HNSCC.

References

YearCitations

Page 1